PMGC subsidiary files 10 US patent applications for EL-22/EL-32 in animal muscle growth

PMGC Holdings Inc.

NorthStrive Biosciences, wholly owned by PMGC, filed ten US patent applications expanding EL-22 and EL-32 into animal health and agriculture.
Applications cover EL-22 (5 patents) and EL-32 (5 patents) for livestock, aquaculture, and poultry including muscle growth and yield.
Two applications target livestock muscle growth: EL-22 (19/541,209) and EL-32 (19/540,888).
Additional filings address emissions reduction in livestock and aquaculture, and poultry muscle development.
This expands PMGC's IP portfolio beyond human aesthetic medicine into animal agriculture markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.